Clinical Trial Update: A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects [Phase 4]

View source ↗

Summary

This Phase 4 randomized trial evaluated the safety and efficacy of Taneasy 600mg Granules versus Fluimucil 600mg Granules in patients with COPD and has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluimucil 600mg Granules (N-acetylcysteine)
• Taneasy 600mg Granules

Snippet

Sponsor: Bun Yao Biotechnology Co., Ltd | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Phase 4 | Status: COMPLETED